These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2799260)
21. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam. Mechan AO; Moran PM; Elliott M; Young AJ; Joseph MH; Green R Psychopharmacology (Berl); 2002 Jan; 159(2):188-95. PubMed ID: 11862348 [TBL] [Abstract][Full Text] [Related]
22. Effect of nicergoline on learning and memory. Voronina TA; Nerobkova LN; Garibova TL; Dikova M; Nikolov R; Nikolova M; Markina NV Methods Find Exp Clin Pharmacol; 1988 Jul; 10(7):431-5. PubMed ID: 3419247 [TBL] [Abstract][Full Text] [Related]
23. Aging effects on elevated plus maze behavior in spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male and female rats. Ferguson SA; Gray EP Physiol Behav; 2005 Aug; 85(5):621-8. PubMed ID: 16043200 [TBL] [Abstract][Full Text] [Related]
24. Effect of different illumination levels on rat behavior in the elevated plus-maze. Garcia AM; Cardenas FP; Morato S Physiol Behav; 2005 Jun; 85(3):265-70. PubMed ID: 15927214 [TBL] [Abstract][Full Text] [Related]
25. Analysis of behavioral asymmetries in the elevated plus-maze and in the T-maze. Schwarting RK; Borta A J Neurosci Methods; 2005 Feb; 141(2):251-60. PubMed ID: 15661307 [TBL] [Abstract][Full Text] [Related]
26. An approach to evaluate the ability of rats to discriminate different levels of illumination in the plus maze test: effects of scopolamine. de Araújo Godinho MA; Meneghini L; Lucinda AM; Borges FR; Sakae DY; Marino Neto J; Paschoalini MA; de Lima TC; Faria MS Behav Brain Res; 2007 Jun; 180(1):86-94. PubMed ID: 17408761 [TBL] [Abstract][Full Text] [Related]
27. Working memory (recognition of conspecific identity) in the genetically hypertensive rats of Koletsky type and in the rats of Wistar strain. Golda V Homeost Health Dis; 1991; 33(3):149-50. PubMed ID: 1818677 [No Abstract] [Full Text] [Related]
28. Ambivalent effect of long lasting terguride treatment on genetically based glycide and lipid metabolism abnormalities in SHR/N-cp Koletsky rats. Golda V Acta Medica (Hradec Kralove); 1998; 41(2):81-5. PubMed ID: 9729641 [TBL] [Abstract][Full Text] [Related]
29. Prenatal stress produces more behavioral alterations than maternal separation in the elevated plus-maze and in the elevated T-maze. Estanislau C; Morato S Behav Brain Res; 2005 Aug; 163(1):70-7. PubMed ID: 15941599 [TBL] [Abstract][Full Text] [Related]
30. Genetic differences in the elevated plus-maze persist after first exposure of inbred rats to the test apparatus. Izídio GS; Spricigo L; Ramos A Behav Processes; 2005 Feb; 68(2):129-34. PubMed ID: 15686823 [TBL] [Abstract][Full Text] [Related]
31. Thermal stress decreases general motor activity of rats in the elevated plus-maze but does not alter aversion to the open arms. Martinez RC; Garcia AM; Lamprea MR; Morato S Behav Brain Res; 2007 Aug; 182(1):135-9. PubMed ID: 17561281 [TBL] [Abstract][Full Text] [Related]
32. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Ramos A; Pereira E; Martins GC; Wehrmeister TD; Izídio GS Behav Brain Res; 2008 Nov; 193(2):277-88. PubMed ID: 18590774 [TBL] [Abstract][Full Text] [Related]
33. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats. Palenicek T; Votava M; Bubenikova V; Horacek J Physiol Behav; 2005 Nov; 86(4):546-53. PubMed ID: 16233904 [TBL] [Abstract][Full Text] [Related]
34. Behavioral alterations in adolescent and adult rats caused by a brief subtoxic exposure to chlorpyrifos during neurulation. Icenogle LM; Christopher NC; Blackwelder WP; Caldwell DP; Qiao D; Seidler FJ; Slotkin TA; Levin ED Neurotoxicol Teratol; 2004; 26(1):95-101. PubMed ID: 15001218 [TBL] [Abstract][Full Text] [Related]
35. AIDA influences behavior in rats pretreated with baclofen. Car H; Nadlewska A; Oksztel R; Wiśniewski K Pol J Pharmacol; 2001; 53(3):245-52. PubMed ID: 11785925 [TBL] [Abstract][Full Text] [Related]
36. Effect on an ergoline derivate-nicergoline (Sermion) on methylandrostenediol-induced hypertension in the rat. Molteni A; Nickerson PA; Brownie AC; Liu K Arch Int Pharmacodyn Ther; 1980 Sep; 247(1):119-34. PubMed ID: 7447555 [TBL] [Abstract][Full Text] [Related]
37. Comparative studies on the effects of the nootropic drugs adafenoxate, meclofenoxate and piracetam, and of citicholine on scopolamine-impaired memory, exploratory behavior and physical capabilities (experiments on rats and mice). Petkov VD; Mosharrof AH; Petkov VV Acta Physiol Pharmacol Bulg; 1988; 14(1):3-13. PubMed ID: 3136617 [TBL] [Abstract][Full Text] [Related]
38. [Behavioral pharmacological properties of nicergoline. Effects on gross-behavior in rats and monkeys and on DRL response, CER, and CAR in rats]. Yamamura M; Maeda K; Nakagawa H; Ishida R Nihon Yakurigaku Zasshi; 1986 Feb; 87(2):209-21. PubMed ID: 3699631 [TBL] [Abstract][Full Text] [Related]
39. Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs. Kulkarni SK; Singh K; Bishnoi M Methods Find Exp Clin Pharmacol; 2007 Jun; 29(5):343-8. PubMed ID: 17805436 [TBL] [Abstract][Full Text] [Related]
40. Effect of melatonin on exploration and anxiety in normotensive and hypertensive rats with high activity of renin-angiotensin system. Krsková L; Vrabcová M; Zeman M Neuro Endocrinol Lett; 2007 Jun; 28(3):295-301. PubMed ID: 17627265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]